Table: Kringle Pharma - Q1 parent results

Kringle Pharma

14/02/2022 06:00

Feb 14 (Reuters)- 
             Kringle Pharma, Inc. 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended        Year to   
                Dec 31, 2021        Dec 31, 2020       Sep 30, 2022  
                   LATEST             YEAR-AGO            LATEST     
                   RESULTS             RESULTS           FORECAST    
  Sales            13 mln              94 mln            355 mln     
                 (-85.4 pct)                           (+22.6 pct)   
  Operating     loss 120 mln         loss 45 mln        loss 1.36    
  Recurring     loss 128 mln         loss 61 mln        loss 1.30    
  Net           loss 129 mln         loss 62 mln        loss 1.30    
  EPS          loss 29.02 yen      loss 16.94 yen    loss 299.22 yen 
  Ann Div                                NIL               NIL       
  -Q2 div                                                  NIL       
  -Q4 div                                NIL               NIL       
  
  NOTE - Kringle Pharma, Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4884.T